Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Clinical Investigation|June 7, 2021
Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directionsMaria G Filippa, Maria G Tektonidou, Aimilia Mantzou, et al.
Neuroscience Letters|December 2, 2015
Expression pattern of the Hedgehog signaling pathway in pituitary adenomasMaria P Yavropoulou, Anna Maladaki, Konstantina Topouridou, et al.
World Journal of Gastroenterology|July 30, 2014
Postprandial response of bone turnover markers in patients with Crohn's diseaseIoannis Karatzoglou, Maria P Yavropoulou, Maria Pikilidou, et al.
Reviews in Endocrine & Metabolic Disorders|August 20, 2024
Primary hyperparathyroidism: from guidelines to outpatient clinicAndrea Palermo, Gaia Tabacco, Polyzois Makras, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 3, 2023
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practiceEvrydiki Kravvariti, Maria-Iosifina Kasdagli, Konstantina Maria Diomatari, et al.
Calcified Tissue International|February 12, 2026
Bone Adverse Events in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Comprehensive Review of the Literature from the Clinical Action Group of the European Calcified Tissue SocietyStella D'Oronzo, Anda Mihaela Naciu, Maria P Yavropoulou, et al.
European Journal of Endocrinology|May 5, 2026
Magnesium as an Endocrine Modulator: Physiological Roles, Clinical Evidence, and Therapeutic PerspectivesAndrea Palermo, Anda Mihaela Naciu, Guido Zavatta, et al.
Calcified Tissue International|January 2, 2021
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2018
Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Maria Pikilidou, et al.
Frontiers in Endocrinology|December 22, 2025
Clinicopathological data and the role of miRNA expression in patients with pheochromocytomas/paragangliomasFoteini Thanasoula, Maria P Yavropoulou, Georgios Kyriakopoulos, et al.
Pageof 12